| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |